U Herrlinger Selected Research

U Herrlinger Research Topics

Disease

12	Neoplasms (Cancer) 01/2019 - 01/2000
10	Glioma (Gliomas) 01/2019 - 01/2000
8	Lymphoma (Lymphomas) 11/2011 - 04/2000
5	Glioblastoma (Glioblastoma Multiforme) 01/2011 - 01/2000
4	Infections 04/2001 - 04/2000
3	Neoplasm Metastasis (Metastasis) 02/2016 - 07/2004
3	Brain Neoplasms (Brain Tumor) 08/2010 - 01/2000
2	Meningioma (Meningiomas) 04/2014 - 12/2010
2	Astrocytoma (Pilocytic Astrocytoma) 01/2011 - 09/2000
2	Leukoencephalopathies 08/2010 - 05/2005
2	Myasthenia Gravis 06/2000 - 05/2000
1	Infarction (Infarctions) 04/2014
1	Necrosis 04/2014
1	Sepsis (Septicemia) 04/2014
1	Pneumonia (Pneumonitis) 04/2014
1	Seizures (Absence Seizure) 01/2010
1	Epilepsy (Aura) 01/2010
1	Drug Resistant Epilepsy 01/2010
1	Hypersensitivity (Allergy) 01/2010
1	Breast Neoplasms (Breast Cancer) 11/2008
1	Intraocular Lymphoma 10/2008
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2006
1	Brain Diseases (Brain Disorder) 05/2005
1	Respiratory Insufficiency (Respiratory Failure) 03/2005
1	Medulloblastoma 07/2004
1	Disease Progression 07/2004
1	Progressive Multifocal Leukoencephalopathy 10/2003
1	Pathologic Complete Response 08/2002
1	Fistula 03/2002
1	Gliosarcoma 04/2001
1	Virus Diseases (Viral Diseases) 04/2001
1	Hodgkin Disease (Hodgkin's Disease) 06/2000

Drug/Important Bio-Agent (IBA)

5	Methotrexate (Mexate)FDA LinkGeneric 11/2011 - 01/2001
3	Bevacizumab (Avastin)FDA Link 06/2015 - 12/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2015 - 07/2004
2	Temozolomide (Temodar)FDA LinkGeneric 01/2011 - 05/2002
2	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2008 - 01/2001
2	Thymidine KinaseIBA 04/2001 - 04/2000
2	ProdrugsIBA 09/2000 - 01/2000
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 07/2000 - 01/2000
2	CytokinesIBA 07/2000 - 01/2000
2	Azathioprine (Imuran)FDA LinkGeneric 06/2000 - 05/2000
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2019
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2019
1	Biological ProductsIBA 06/2015
1	Etoposide (VP 16)FDA LinkGeneric 01/2011
1	IceIBA 01/2011
1	Ifosfamide FDA LinkGeneric 01/2011
1	Carboplatin (JM8)FDA LinkGeneric 01/2011
1	PlatinumIBA 08/2010
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2010
1	NimustineIBA 01/2009
1	Teniposide (VM 26)FDA Link 01/2009
1	Retinaldehyde (Retinal)IBA 10/2008
1	Rituximab (Mabthera)FDA Link 03/2006
1	Lomustine (CCNU)FDA Link 02/2006
1	Procarbazine (Matulane)FDA Link 02/2006
1	Vincristine (Oncovin)FDA LinkGeneric 02/2006
1	Imatinib Mesylate (Gleevec)FDA Link 03/2005
1	DNA (Deoxyribonucleic Acid)IBA 10/2003
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2002
1	fialuridineIBA 04/2001
1	beta-Galactosidase (Lactaid)IBA 04/2001
1	Arabinofuranosyluracil (Ara U)IBA 04/2001
1	Cytosine DeaminaseIBA 11/2000
1	treosulfanIBA 09/2000
1	LuciferasesIBA 09/2000
1	Complementary DNA (cDNA)IBA 07/2000
1	Viral ProteinsIBA 07/2000
1	Hexadimethrine BromideIBA 07/2000
1	Membrane Proteins (Integral Membrane Proteins)IBA 06/2000
1	MimosineIBA 04/2000

Therapy/Procedure

14	Therapeutics 09/2018 - 01/2000
8	Drug Therapy (Chemotherapy) 01/2011 - 01/2000
4	Radiotherapy 08/2010 - 01/2001
1	Combination Drug Therapy (Combination Chemotherapy) 11/2011
1	Denervation 01/2010
1	Electrodes (Electrode) 01/2010
1	Vitrectomy 10/2008
1	Stem Cell Transplantation 03/2006
1	Aftercare (After-Treatment) 08/2002
1	Combined Modality Therapy 01/2001
1	Salvage Therapy 09/2000